Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in Tennessee | 519 Studies

Clinical Trials LymphomaTennessee

Lymphoma Clinical Trials in Tennessee

Find 519 clinical trials for lymphoma near Tennessee. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Tennessee

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 321-340 of 519 trials

Active not recruitingRituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete RemissionThis phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual…NCT03267433·Birmingham, Alabama and 374 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedA Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,The purpose of this study is to determine whether an investigational immuno-therapy combination, nivolumab with Brentuximab vedotin compared to Brentuximab vedotin alone is safe…NCT03138499·Duarte, California and 21 others

RecruitingStudy of NX-5948 in Combination With Other Agents in Adults With B-cell MalignanciesThe study will evaluate NX-5948 (bexobrutideg) in combination with venetoclax with or without an anti-CD20 antibody (rituximab or obinutuzumab) in second-line or higher (2L+)…NCT07520006·Aurora, Colorado and 5 others

CompletedA Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)This open-label, multicenter study will evaluate the efficacy and safety of obinutuzumab \[RO5072759 (GA101)\] in combination with CHOP (Cyclophosphamide, Doxorubicin…NCT01414855·Birmingham, Alabama and 37 others

SuspendedLow-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis FungoidesThis clinical trial studies low- dose total skin electron therapy in treating patients with stage IB-IIIA mycosis fungoides that has not responded to previous treatment…NCT02702310·Nashville, Tennessee

TerminatedStudy of SNX281 in Subjects With Advanced Solid Tumors and LymphomaThis clinical trial is evaluating a drug called SNX281 given by itself and in combination with pembrolizumab (KEYTRUDA®) in participants with advanced solid tumors and lymphoma.NCT04609579·Denver, Colorado and 3 others

RecruitingFamilial Investigations of Childhood Cancer PredispositionNOTE: This is a research study and is not meant to be a substitute for clinical genetic testing.NCT03050268·Memphis, Tennessee

Active not recruitingA Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular LymphomaB-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections).NCT05451810·Mobile, Alabama and 71 others

CompletedA Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)The purpose of the study is to compare the safety and efficacy of Tafasitamab with BEN versus RTX with BEN in adult patients with relapsed of refractory DLBCL.NCT02763319·Anaheim, California and 157 others

UnknownRituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and kill them or carry cancer-killing substances to them.NCT00258336·Nashville, Tennessee

CompletedBortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell LymphomaThis phase II trial studies how well bortezomib and vorinostat work in treating patients with recurrent mantle cell lymphoma or recurrent and/or refractory diffuse large B-cell…NCT00703664·Tampa, Florida and 11 others

RecruitingA Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesThis is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-2127 in patients with advanced B-cell…NCT04830137·Duarte, California and 15 others

Active not recruitingA Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)Phase 3 randomized, double-blind, placebo-controlled, study assessing the efficacy and safety of acalabrutinib plus rituximab,cyclophosphamide, doxorubicin, vincristine, and…NCT04529772·Tucson, Arizona and 242 others

RecruitingA Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyThis Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients…NCT07188558·Gilbert, Arizona and 35 others

CompletedA Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)This is an open-label, multicenter, Phase 2 study to determine the safety, PK, and efficacy of lisocabtagene maraleucel (JCAR017) in subjects who have relapsed from, or are…NCT03744676·Los Angeles, California and 22 others

WithdrawnA Study of Duvelisib in Combination With Rituximab and Bendamustine vs Placebo in Combination With Rituximab and Bendamustine in Subjects With Previously-Treated Indolent Non-Hodgkin Lymphoma (BRAVURA)This study will evaluate the efficacy and safety of duvelisib in combination with bendamustine and rituximab (DBR) vs placebo in combination with bendamustine and rituximab (PBR)…NCT02576275·Plainville, Connecticut and 6 others

CompletedSafety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's LymphomaThis study is designed to provide evidence of the safety and a preliminary understanding of the efficacy of AME 133v.NCT00354926·Birmingham, Alabama and 10 others

RecruitingA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsPhase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies…NCT04094610·Los Angeles, California and 67 others

CompletedStem Cell Transplantation as Immunotherapy for Hematologic MalignanciesBlood and marrow stem cell transplant has improved the outcome for patients with high-risk hematologic malignancies.NCT00143559·Memphis, Tennessee

CompletedAdapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor HealthThis research study will test the efficacy of interactive, web-based interventions that improve diet, physical activity and weight management changes among early stage survivors…NCT04000880·Birmingham, Alabama and 1 other

PreviousPage 17 of 26Next

Other Conditions in Tennessee

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia